Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 994 entries
View as:

A Phase II Study to Treat Advanced Malignant Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00427440 Org: User:
Start: 11/30/06 End: 04/30/13 Due: 04/30/14

Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT00721734 Org: User:
Start: 11/30/08 End: 11/30/12 Due: 11/30/13

STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00364845 Org: User:
Start: 09/30/06 End: 02/28/09 Due: 02/28/10

Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00121030 Org: User:
Start: 10/31/02 End: 12/31/03 Due: 12/31/04

Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk

Phase: N/A Priority: Normal
NCT ID: NCT01953328 Org: User:
Start: 10/31/13 End: 06/30/14 Due: 06/30/15

Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)

Phase: N/A Priority: Normal
NCT ID: NCT03298412 Org: User:
Start: 05/23/18 End: 09/30/19 Due: 09/30/20

An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density

Phase: N/A Priority: Normal
NCT ID: NCT00325468 Org: User:
Start: 05/01/06 End: 08/02/12 Due: 08/02/13

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk

Phase: N/A Priority: Normal
NCT ID: NCT01764633 Org: User:
Start: 02/08/13 End: 11/11/16 Due: 11/11/17

Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00091832 Org: User:
Start: 09/30/04 End: 10/31/06 Due: 10/31/07

A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00095264 Org: User:
Start: 10/31/04 End: - Due: -

Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00113776 Org: User:
Start: - End: - Due: -

A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05975073 Org: User:
Start: 08/01/23 End: 08/10/25 Due: 08/10/26

Blinatumomab Versus Standard of Care Chemotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)

Phase: N/A Priority: Normal
NCT ID: NCT02013167 Org: User:
Start: 01/03/14 End: 03/14/17 Due: 03/14/18

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00838201 Org: User:
Start: 02/01/09 End: 05/03/12 Due: 05/03/13

Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)

Phase: N/A Priority: Normal
NCT ID: NCT00947297 Org: User:
Start: 11/30/09 End: 11/30/11 Due: 11/30/12

Denosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01824342 Org: User:
Start: 01/31/11 End: 02/28/14 Due: 02/28/15

Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta

Phase: N/A Priority: Normal
NCT ID: NCT04545554 Org: User:
Start: 01/21/21 End: 03/30/23 Due: 03/30/24

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00413283 Org: User:
Start: 12/31/06 End: 02/28/09 Due: 02/28/10

Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00523341 Org: User:
Start: 08/07/07 End: 07/19/15 Due: 07/19/16

Evaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)

Phase: N/A Priority: Normal
NCT ID: NCT00111475 Org: User:
Start: 07/01/02 End: 06/17/04 Due: 06/17/05

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

Phase: N/A Priority: Normal
NCT ID: NCT04185883 Org: User:
Start: 12/17/19 End: 12/05/27 Due: 12/05/28

Expanded Access of Sotorasib

Phase: N/A Priority: Normal
NCT ID: NCT04667234 Org: User:
Start: - End: - Due: -

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01313221 Org: User:
Start: 04/30/11 End: 05/31/13 Due: 05/31/14

STAAR-1 Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT00369772 Org: User:
Start: 02/28/02 End: 05/31/04 Due: 05/31/05

Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT01785875 Org: User:
Start: 07/31/13 End: 07/01/15 Due: 07/01/16